These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 37637464)
1. Assessment of transmissibility and measures effectiveness of SARS in 8 regions, China, 2002-2003. Rui J; Qu H; Zhang S; Liu H; Wei H; Abudunaibi B; Li K; Zhao Y; Liu Q; Fang K; Gavotte L; Frutos R; Chen T Front Cell Infect Microbiol; 2023; 13():1212473. PubMed ID: 37637464 [TBL] [Abstract][Full Text] [Related]
2. The time-varying transmission dynamics of COVID-19 and synchronous public health interventions in China. Xiao J; Hu J; He G; Liu T; Kang M; Rong Z; Lin L; Zhong H; Huang Q; Deng A; Zeng W; Tan X; Zeng S; Zhu Z; Li J; Gong D; Wan D; Chen S; Guo L; Li Y; Li Y; Sun L; Liang W; Song T; He J; Ma W Int J Infect Dis; 2021 Feb; 103():617-623. PubMed ID: 33181330 [TBL] [Abstract][Full Text] [Related]
3. Epidemiological Characteristics and Transmissibility for SARS-CoV-2 of Population Level and Cluster Level in a Chinese City. Yu S; Cui S; Rui J; Zhao Z; Deng B; Liu C; Li K; Wang Y; Yang Z; Li Q; Chen T; Wang S Front Public Health; 2021; 9():799536. PubMed ID: 35118044 [TBL] [Abstract][Full Text] [Related]
4. The spatial transmission of SARS-CoV-2 in China under the prevention and control measures at the early outbreak. Liu J; Zhou Y; Ye C; Zhang G; Zhang F; Song C Arch Public Health; 2021 Jan; 79(1):8. PubMed ID: 33441168 [TBL] [Abstract][Full Text] [Related]
5. Evaluating the effectiveness of measures to control the novel coronavirus disease 2019 in Jilin Province, China. Zhao Q; Wang Y; Yang M; Li M; Zhao Z; Lu X; Shen B; Luan B; Zhao Y; Cao B; Yao L; Zhao B; Su Y; Chen T BMC Infect Dis; 2021 Mar; 21(1):245. PubMed ID: 33676420 [TBL] [Abstract][Full Text] [Related]
6. The epidemiological characteristics and effectiveness of countermeasures to contain coronavirus disease 2019 in Ningbo City, Zhejiang Province, China. Lao X; Luo L; Lei Z; Fang T; Chen Y; Liu Y; Ding K; Zhang D; Wang R; Zhao Z; Rui J; Zhu Y; Xu J; Wang Y; Yang M; Yi B; Chen T Sci Rep; 2021 May; 11(1):9545. PubMed ID: 33953243 [TBL] [Abstract][Full Text] [Related]
7. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. Chu H; Chan JF; Yuen TT; Shuai H; Yuan S; Wang Y; Hu B; Yip CC; Tsang JO; Huang X; Chai Y; Yang D; Hou Y; Chik KK; Zhang X; Fung AY; Tsoi HW; Cai JP; Chan WM; Ip JD; Chu AW; Zhou J; Lung DC; Kok KH; To KK; Tsang OT; Chan KH; Yuen KY Lancet Microbe; 2020 May; 1(1):e14-e23. PubMed ID: 32835326 [TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study. Lancet Microbe; ; . PubMed ID: 33230504 [TBL] [Abstract][Full Text] [Related]